Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANNA pharmacokinetics study in pregnant women with HIV
2008-006158-16Phase 4Active
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of emtricitabine, raltegravir, etravirine, tenofovir disoproxil fumarate, atazanavir and 14 more in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Plasma concentrations of antiretroviral agents. Started Nov 2008; status: active.
02
Drugs
emtricitabineraltegraviretravirinetenofovir disoproxil fumarateatazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-006158-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006158-16.